» Articles » PMID: 23892886

Improvement in Hereditary Hemorrhagic Telangiectasia After Treatment with the Phosphoinositide 3-kinase Inhibitor BKM120

Overview
Journal Ann Hematol
Specialty Hematology
Date 2013 Jul 30
PMID 23892886
Citations 6
Authors
Affiliations
Soon will be listed here.
Citing Articles

Hereditary hemorrhagic telangiectasia: from signaling insights to therapeutic advances.

Al Tabosh T, Al Tarrass M, Tourvieilhe L, Guilhem A, Dupuis-Girod S, Bailly S J Clin Invest. 2024; 134(4).

PMID: 38357927 PMC: 10866657. DOI: 10.1172/JCI176379.


Perioperative Complications and Long-Term Follow-Up of Liver Transplantation in Hemorrhagic Hereditary Telangiectasia: Report of Three Cases and Systematic Review.

Riera-Mestre A, Cerda P, Guzman Y, Iriarte A, Torroella A, Mora-Lujan J J Clin Med. 2022; 11(19).

PMID: 36233492 PMC: 9573297. DOI: 10.3390/jcm11195624.


Pathogenesis and therapy of arteriovenous malformations: A case report and narrative review.

Tessier S, Lipton B, Ido F, Longo S, Nanda S Int J Crit Illn Inj Sci. 2021; 11(3):167-176.

PMID: 34760664 PMC: 8547675. DOI: 10.4103/IJCIIS.IJCIIS_127_20.


Review of Pharmacological Strategies with Repurposed Drugs for Hereditary Hemorrhagic Telangiectasia Related Bleeding.

Albinana V, Cuesta A, de Rojas-P I, Gallardo-Vara E, Recio-Poveda L, Bernabeu C J Clin Med. 2020; 9(6).

PMID: 32517280 PMC: 7356836. DOI: 10.3390/jcm9061766.


Future treatments for hereditary hemorrhagic telangiectasia.

Robert F, Desroches-Castan A, Bailly S, Dupuis-Girod S, Feige J Orphanet J Rare Dis. 2020; 15(1):4.

PMID: 31910860 PMC: 6945546. DOI: 10.1186/s13023-019-1281-4.